Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2011 10:35 ET | Source: Pluri Inc.

Pluristem Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock

HAIFA, Israel, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced the closing of its previously announced firm commitment underwritten public...
January 27, 2011 09:32 ET | Source: Pluri Inc.

Pluristem Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock

HAIFA, Israel, Jan. 27, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) announced that it has priced a firm commitment underwritten public offering of 11,000,000 units,...
January 26, 2011 16:03 ET | Source: Pluri Inc.

Pluristem Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

HAIFA, Israel, Jan. 26, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) announced today that it intends, subject to market and other conditions, to offer its common...
January 18, 2011 07:58 ET | Source: Pluri Inc.

Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb Ischemia (CLI) Under a Joint FDA-EMA Protocol, and a Phase II Clinical Trial in Intermittent Claudication (IC)

HAIFA, Israel, Jan. 18, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced the successful completion of a parallel scientific advisory process with the...
January 04, 2011 02:15 ET | Source: Pluri Inc.

Shares of Pluristem Therapeutics to Begin Trading on Four Equity Indexes on the Tel Aviv Stock Exchange (TASE) Beginning January 9, 2011

HAIFA, Israel, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI), today announced that the Tel-Aviv Stock Exchange ("TASE") has approved the inclusion of the company's...
December 12, 2010 04:30 ET | Source: Pluri Inc.

Pluristem Therapeutics Approved for Dual Listing on the Tel Aviv Stock Exchange (TASE)

Company Anticipates Joining four of TASE's Indexes Pluristem will open trading on the TASE on December 19 and will host a welcoming ceremony for investors and a press conference for...
November 16, 2010 08:00 ET | Source: Pluri Inc.

Pluristem to Present at the Commercial Translation of Regenerative Medicine Conference

HAIFA, Israel, Nov. 16, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today reported that the company will present two key aspects of its clinical trials -- quality and...
April 27, 2010 07:10 ET | Source: Pluri Inc.

Pluristem Therapeutics Announces Interim Top-Line Results From PLX-PAD Clinical Trials

HAIFA, Israel, April 27, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced interim top-line results from its Phase I clinical trials utilizing its...
April 27, 2010 07:00 ET | Source: Pluri Inc.

Pluristem Therapeutics Raises $2.7 Million in Private Placement of Restricted Common Stock

HAIFA, Israel, April 27, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has entered into definitive agreements with selected investors to sell...
March 23, 2010 08:32 ET | Source: Pluri Inc.

Pluristem Therapeutics Granted European Union Patent for PluriX(TM) Three-Dimensional (3D) Bioreactor System

HAIFA, Israel, March 23, 2010 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (DAX:PJT) today announced that it has been granted a European Patent on its core 3D cell expansion...